DEA Schedule CII

Strength

2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1

NDC

57664033788

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

2/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211715

On Market Since

3/5/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

-2.2%

6M

+4.7%

1Y

-21.6%

3Y

-24.4%

5Y

-27.0%

All

-67.2%